Место пробиотиков в современной клинической практике
Место пробиотиков в современной клинической практике
Плотникова Е.Ю., Захарова Ю.В. Место пробиотиков в современной клинической практике. Педиатрия (Прил. к журн. Consilium Medicum). 2018; 1: 95–99.
DOI: 10.26442/2413-8460_2018.1.95-99
DOI: 10.26442/2413-8460_2018.1.95-99
DOI: 10.26442/2413-8460_2018.1.95-99
________________________________________________
DOI: 10.26442/2413-8460_2018.1.95-99
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
В статье приводятся исторические данные использования пробиотиков и последние законодательные всемирные и отечественные документы по их использованию. Разнообразие микробиома важно для поддержания здоровья, а пробиотики широкого спектра действия могут повысить эффективность лечения при разных заболеваниях. Приводятся группы заболеваний, при которых рекомендуется прием пробиотиков, и уровни доказательности их применения в соответствии с критериями Оксфордского центра медицины, основанной на доказательствах. Описаны результаты подробного исследования средства Максилак®.
Ключевые слова: пробиотики, микробиом, синбиотик, Максилак.
Key words: probiotics, microbiome, synbiotics, Maxilac.
Ключевые слова: пробиотики, микробиом, синбиотик, Максилак.
________________________________________________
Key words: probiotics, microbiome, synbiotics, Maxilac.
Список литературы
1. Gao C, Ganesh BP, Shi Z et al. Gut Microbe-Mediated Suppression of Inflammation-Associated Colon Carcinogenesis by Luminal Histamine Production. Am J Pathol 2017; 187 (10): 2323–36.
2. Metchnikoff E. The prolongation of life. New York: G.P.Putnom & Sons, 1908.
3. Nissle A. Die antagonistische Behandlung chronischer Darmstorungen mit Colibakterien. Med Klin 1918; 2: 29–33.
4. Vasiljevic T, Shah NP. Probiotics – from Metchnikoff to bioactives. Int Dairy 2008; 18: 714–28.
5. Vergin F. Anti und Probiotika. Hippokrates 1954; 25: 16–119.
6. Salmine S, Isolauri E, Salmine E. Clinical use of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie Van Leeuwenhoek 1996; 70: 347–5.
7. Food and Agricultural Organization of the United Nations and World Health Organization. Joint FAO/WHO working group report on drafting guidelines for the evaluation of probiotics in food. 2002. http://www.un.org/youthenvoy/2013/09/fao-food-and-agriculture-organization-of-the-united-nations/
8. Hill C, Guarner F, Reid G et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11 (8): 506–14.
9. ГОСТ Р 52349-2005 «Продукты пищевые. Продукты пищевые функциональные. Термины и определения». М.: Стандартинформ, 2015. / GOST R 52349-2005 «Produkty pishchevye. Produkty pishchevye funktsional'nye. Terminy i opredeleniia». M.: Standartinform, 2015. [in Russian]
10. Sanders ME, Guarner F, Guerrant R et al. An update on the use and investigation of probiotics in health and disease. Gut 2013; 62: 787–96.
11. Davenport ER, Sanders JG, Song SJ et al. The human microbiome in evolution. BMC Biol 2017; 15: 127.
12. Van Baarlen P, Wells JM, Kleerebezem M. Regulation of intestinal homeostasis and immunity with probiotic lactobacilli. Trends Immunol 2013; 34: 208–15.
13. Bian G, Gloor GB, Gong A et al. The Gut Microbiota of Healthy Aged Chinese Is Similar to That of the Healthy Young. mSphere 2017; 2 (5): e00327-17.
14. Odamaki T, Kato K, Sugahara H et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol 2016; 16: 90.
15. Jones RJ, Hussein HM, Zagorec M et al. Isolation of lactic acid bacteria with inhibitory activity against pathogens and spoilage organisms associated with fresh meat. Food Microbiol 2008; 25 (2): 228–34.
16. Paredes-Paredes M, Flores-Figueroa J, Dupont HL. Advances in the treatment of travelers' diarrhea. Curr Gastroenterol Rep 2011; 13 (5): 402–7.
17. Wullt M, Johansson Hagslätt ML, Odenholt I, Berggren A. Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent Clostridium difficile–associated diarrhea. Dig Dis Sci 2007; 52 (9): 2082–6.
18. Dickinson B, Surawicz CM. Infectious diarrhea: an overview. Curr Gastroenterol Rep 2014; 16 (8): 399.
19. Gedek BR. Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 1999; 42 (4): 261–4.
20. Shornikova AV, Casas IA, Mykkänen N et al. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis 1997; 16: 1103–7.
21. Gionchetti P, Rizzello F, Morselli C et al. High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum 2007; 50: 2075–82.
22. Saxelin, M. Colonization of the human gastrointestinal tract by probiotic bacteria (Lactobacillus GG). Nutrition Today 1996; 31: 5S–9S.
23. Goldenberg JZ, Lytvyn L, Steurich J et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2015; 12: CD004827.
24. Labdoor. Probiotics rankings. 2016. https://labdoor.com/rankings/probiotics
25. Thomas LV, Suzuki K, Zhao J. Probiotics: a proactive approach to health. A symposium report. Br J Nutr 2015; 114 (1): S1–S15.
26. Государственный реестр лекарственных средств Российской Федерации. http:// grls.rosminzdrav.ru/ / Gosudarstvennyi reestr lekarstvennykh sredstv Rossiiskoi Federatsii. http:// grls.rosminzdrav.ru/ [in Russian]
27. Осипова И.Г., Евлашкина В.Ф., Давыдов Д.С., Саканян Е.И. Общие фармакопейные статьи на препараты пробиотики для государственной Фармакопеи РФ XIII издания – первый опыт в мировой фармакопейной практике. Междунар. журн. прикладных и фундаментальных исследований. 2016; 6 (2): 272–6. / Osipova I.G., Evlashkina V.F., Davydov D.S., Sakanian E.I. Obshchie farmakopeinye stat'i na preparaty probiotiki dlia gosudarstvennoi Farmakopei RF XIII izdaniia – pervyi opyt v mirovoi farmakopeinoi praktike. Mezhdunar. zhurn. prikladnykh i fundamental'nykh issledovanii. 2016; 6 (2): 272–6. [in Russian]
28. ОФС.1.7.1.0008.15 Пробиотики. http://pharmacopoeia.ru/ofs-1-7-1-0008-15-probiotiki/ / OFS.1.7.1.0008.15 Probiotiki. http://pharmacopoeia.ru/ofs-1-7-1-0008-15-probiotiki/ [in Russian]
29. Мазанкова Л.Н., Лыкова Е.А. Пробиотики: характеристика препаратов и выбор в педиатрической практике. Детские инфекции. 2004; 1: 18–23. / Mazankova L.N., Lykova E.A. Probiotiki: kharakteristika preparatov i vybor v pediatricheskoi praktike. Detskie infektsii. 2004; 1: 18–23. [in Russian]
30. Guarner F, Khan AG, Garisch J et al. Всемирная гастроэнтерологическая организация. Практические рекомендации. Пробиотики и пребиотики. http://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probioti... / Guarner F, Khan AG, Garisch J et al. Vsemirnaia gastroenterologicheskaia organizatsiia. Prakticheskie rekomendatsii. Probiotiki i prebiotiki. http://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probioti... [in Russian]
31. 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/index.aspx?o=5653
32. Lau CS, Chamberlain RS. Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Int J Gen Med 2016; 9: 27–37.
33. Hamad A, Fragkos KC, Forbes A. A systematic review and meta-analysis of probiotics for the management of radiation induced bowel disease. Clin Nutr Edinb Scotl 2013; 32 (3): 353–60.
34. Dang Y, Reinhardt JD, Zhou X, Zhang G. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis. PloS One 2014; 9 (11): e111030.
2. Metchnikoff E. The prolongation of life. New York: G.P.Putnom & Sons, 1908.
3. Nissle A. Die antagonistische Behandlung chronischer Darmstorungen mit Colibakterien. Med Klin 1918; 2: 29–33.
4. Vasiljevic T, Shah NP. Probiotics – from Metchnikoff to bioactives. Int Dairy 2008; 18: 714–28.
5. Vergin F. Anti und Probiotika. Hippokrates 1954; 25: 16–119.
6. Salmine S, Isolauri E, Salmine E. Clinical use of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie Van Leeuwenhoek 1996; 70: 347–5.
7. Food and Agricultural Organization of the United Nations and World Health Organization. Joint FAO/WHO working group report on drafting guidelines for the evaluation of probiotics in food. 2002. http://www.un.org/youthenvoy/2013/09/fao-food-and-agriculture-organization-of-the-united-nations/
8. Hill C, Guarner F, Reid G et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11 (8): 506–14.
9. GOST R 52349-2005 «Produkty pishchevye. Produkty pishchevye funktsional'nye. Terminy i opredeleniia». M.: Standartinform, 2015. [in Russian]
10. Sanders ME, Guarner F, Guerrant R et al. An update on the use and investigation of probiotics in health and disease. Gut 2013; 62: 787–96.
11. Davenport ER, Sanders JG, Song SJ et al. The human microbiome in evolution. BMC Biol 2017; 15: 127.
12. Van Baarlen P, Wells JM, Kleerebezem M. Regulation of intestinal homeostasis and immunity with probiotic lactobacilli. Trends Immunol 2013; 34: 208–15.
13. Bian G, Gloor GB, Gong A et al. The Gut Microbiota of Healthy Aged Chinese Is Similar to That of the Healthy Young. mSphere 2017; 2 (5): e00327-17.
14. Odamaki T, Kato K, Sugahara H et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol 2016; 16: 90.
15. Jones RJ, Hussein HM, Zagorec M et al. Isolation of lactic acid bacteria with inhibitory activity against pathogens and spoilage organisms associated with fresh meat. Food Microbiol 2008; 25 (2): 228–34.
16. Paredes-Paredes M, Flores-Figueroa J, Dupont HL. Advances in the treatment of travelers' diarrhea. Curr Gastroenterol Rep 2011; 13 (5): 402–7.
17. Wullt M, Johansson Hagslätt ML, Odenholt I, Berggren A. Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent Clostridium difficile–associated diarrhea. Dig Dis Sci 2007; 52 (9): 2082–6.
18. Dickinson B, Surawicz CM. Infectious diarrhea: an overview. Curr Gastroenterol Rep 2014; 16 (8): 399.
19. Gedek BR. Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 1999; 42 (4): 261–4.
20. Shornikova AV, Casas IA, Mykkänen N et al. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis 1997; 16: 1103–7.
21. Gionchetti P, Rizzello F, Morselli C et al. High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum 2007; 50: 2075–82.
22. Saxelin, M. Colonization of the human gastrointestinal tract by probiotic bacteria (Lactobacillus GG). Nutrition Today 1996; 31: 5S–9S.
23. Goldenberg JZ, Lytvyn L, Steurich J et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2015; 12: CD004827.
24. Labdoor. Probiotics rankings. 2016. https://labdoor.com/rankings/probiotics
25. Thomas LV, Suzuki K, Zhao J. Probiotics: a proactive approach to health. A symposium report. Br J Nutr 2015; 114 (1): S1–S15.
26. Gosudarstvennyi reestr lekarstvennykh sredstv Rossiiskoi Federatsii. http:// grls.rosminzdrav.ru/ [in Russian]
27. Osipova I.G., Evlashkina V.F., Davydov D.S., Sakanian E.I. Obshchie farmakopeinye stat'i na preparaty probiotiki dlia gosudarstvennoi Farmakopei RF XIII izdaniia – pervyi opyt v mirovoi farmakopeinoi praktike. Mezhdunar. zhurn. prikladnykh i fundamental'nykh issledovanii. 2016; 6 (2): 272–6. [in Russian]
28. OFS.1.7.1.0008.15 Probiotiki. http://pharmacopoeia.ru/ofs-1-7-1-0008-15-probiotiki/ [in Russian]
29. Mazankova L.N., Lykova E.A. Probiotiki: kharakteristika preparatov i vybor v pediatricheskoi praktike. Detskie infektsii. 2004; 1: 18–23. [in Russian]
30. Guarner F, Khan AG, Garisch J et al. Всемирная гастроэнтерологическая организация. Практические рекомендации. Пробиотики и пребиотики. http://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probioti... / Guarner F, Khan AG, Garisch J et al. Vsemirnaia gastroenterologicheskaia organizatsiia. Prakticheskie rekomendatsii. Probiotiki i prebiotiki. http://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probioti... [in Russian]
31. 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/index.aspx?o=5653
32. Lau CS, Chamberlain RS. Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Int J Gen Med 2016; 9: 27–37.
33. Hamad A, Fragkos KC, Forbes A. A systematic review and meta-analysis of probiotics for the management of radiation induced bowel disease. Clin Nutr Edinb Scotl 2013; 32 (3): 353–60.
34. Dang Y, Reinhardt JD, Zhou X, Zhang G. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis. PloS One 2014; 9 (11): e111030.
2. Metchnikoff E. The prolongation of life. New York: G.P.Putnom & Sons, 1908.
3. Nissle A. Die antagonistische Behandlung chronischer Darmstorungen mit Colibakterien. Med Klin 1918; 2: 29–33.
4. Vasiljevic T, Shah NP. Probiotics – from Metchnikoff to bioactives. Int Dairy 2008; 18: 714–28.
5. Vergin F. Anti und Probiotika. Hippokrates 1954; 25: 16–119.
6. Salmine S, Isolauri E, Salmine E. Clinical use of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie Van Leeuwenhoek 1996; 70: 347–5.
7. Food and Agricultural Organization of the United Nations and World Health Organization. Joint FAO/WHO working group report on drafting guidelines for the evaluation of probiotics in food. 2002. http://www.un.org/youthenvoy/2013/09/fao-food-and-agriculture-organization-of-the-united-nations/
8. Hill C, Guarner F, Reid G et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11 (8): 506–14.
9. ГОСТ Р 52349-2005 «Продукты пищевые. Продукты пищевые функциональные. Термины и определения». М.: Стандартинформ, 2015. / GOST R 52349-2005 «Produkty pishchevye. Produkty pishchevye funktsional'nye. Terminy i opredeleniia». M.: Standartinform, 2015. [in Russian]
10. Sanders ME, Guarner F, Guerrant R et al. An update on the use and investigation of probiotics in health and disease. Gut 2013; 62: 787–96.
11. Davenport ER, Sanders JG, Song SJ et al. The human microbiome in evolution. BMC Biol 2017; 15: 127.
12. Van Baarlen P, Wells JM, Kleerebezem M. Regulation of intestinal homeostasis and immunity with probiotic lactobacilli. Trends Immunol 2013; 34: 208–15.
13. Bian G, Gloor GB, Gong A et al. The Gut Microbiota of Healthy Aged Chinese Is Similar to That of the Healthy Young. mSphere 2017; 2 (5): e00327-17.
14. Odamaki T, Kato K, Sugahara H et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol 2016; 16: 90.
15. Jones RJ, Hussein HM, Zagorec M et al. Isolation of lactic acid bacteria with inhibitory activity against pathogens and spoilage organisms associated with fresh meat. Food Microbiol 2008; 25 (2): 228–34.
16. Paredes-Paredes M, Flores-Figueroa J, Dupont HL. Advances in the treatment of travelers' diarrhea. Curr Gastroenterol Rep 2011; 13 (5): 402–7.
17. Wullt M, Johansson Hagslätt ML, Odenholt I, Berggren A. Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent Clostridium difficile–associated diarrhea. Dig Dis Sci 2007; 52 (9): 2082–6.
18. Dickinson B, Surawicz CM. Infectious diarrhea: an overview. Curr Gastroenterol Rep 2014; 16 (8): 399.
19. Gedek BR. Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 1999; 42 (4): 261–4.
20. Shornikova AV, Casas IA, Mykkänen N et al. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis 1997; 16: 1103–7.
21. Gionchetti P, Rizzello F, Morselli C et al. High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum 2007; 50: 2075–82.
22. Saxelin, M. Colonization of the human gastrointestinal tract by probiotic bacteria (Lactobacillus GG). Nutrition Today 1996; 31: 5S–9S.
23. Goldenberg JZ, Lytvyn L, Steurich J et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2015; 12: CD004827.
24. Labdoor. Probiotics rankings. 2016. https://labdoor.com/rankings/probiotics
25. Thomas LV, Suzuki K, Zhao J. Probiotics: a proactive approach to health. A symposium report. Br J Nutr 2015; 114 (1): S1–S15.
26. Государственный реестр лекарственных средств Российской Федерации. http:// grls.rosminzdrav.ru/ / Gosudarstvennyi reestr lekarstvennykh sredstv Rossiiskoi Federatsii. http:// grls.rosminzdrav.ru/ [in Russian]
27. Осипова И.Г., Евлашкина В.Ф., Давыдов Д.С., Саканян Е.И. Общие фармакопейные статьи на препараты пробиотики для государственной Фармакопеи РФ XIII издания – первый опыт в мировой фармакопейной практике. Междунар. журн. прикладных и фундаментальных исследований. 2016; 6 (2): 272–6. / Osipova I.G., Evlashkina V.F., Davydov D.S., Sakanian E.I. Obshchie farmakopeinye stat'i na preparaty probiotiki dlia gosudarstvennoi Farmakopei RF XIII izdaniia – pervyi opyt v mirovoi farmakopeinoi praktike. Mezhdunar. zhurn. prikladnykh i fundamental'nykh issledovanii. 2016; 6 (2): 272–6. [in Russian]
28. ОФС.1.7.1.0008.15 Пробиотики. http://pharmacopoeia.ru/ofs-1-7-1-0008-15-probiotiki/ / OFS.1.7.1.0008.15 Probiotiki. http://pharmacopoeia.ru/ofs-1-7-1-0008-15-probiotiki/ [in Russian]
29. Мазанкова Л.Н., Лыкова Е.А. Пробиотики: характеристика препаратов и выбор в педиатрической практике. Детские инфекции. 2004; 1: 18–23. / Mazankova L.N., Lykova E.A. Probiotiki: kharakteristika preparatov i vybor v pediatricheskoi praktike. Detskie infektsii. 2004; 1: 18–23. [in Russian]
30. Guarner F, Khan AG, Garisch J et al. Всемирная гастроэнтерологическая организация. Практические рекомендации. Пробиотики и пребиотики. http://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probioti... / Guarner F, Khan AG, Garisch J et al. Vsemirnaia gastroenterologicheskaia organizatsiia. Prakticheskie rekomendatsii. Probiotiki i prebiotiki. http://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probioti... [in Russian]
31. 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/index.aspx?o=5653
32. Lau CS, Chamberlain RS. Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Int J Gen Med 2016; 9: 27–37.
33. Hamad A, Fragkos KC, Forbes A. A systematic review and meta-analysis of probiotics for the management of radiation induced bowel disease. Clin Nutr Edinb Scotl 2013; 32 (3): 353–60.
34. Dang Y, Reinhardt JD, Zhou X, Zhang G. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis. PloS One 2014; 9 (11): e111030.
________________________________________________
2. Metchnikoff E. The prolongation of life. New York: G.P.Putnom & Sons, 1908.
3. Nissle A. Die antagonistische Behandlung chronischer Darmstorungen mit Colibakterien. Med Klin 1918; 2: 29–33.
4. Vasiljevic T, Shah NP. Probiotics – from Metchnikoff to bioactives. Int Dairy 2008; 18: 714–28.
5. Vergin F. Anti und Probiotika. Hippokrates 1954; 25: 16–119.
6. Salmine S, Isolauri E, Salmine E. Clinical use of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie Van Leeuwenhoek 1996; 70: 347–5.
7. Food and Agricultural Organization of the United Nations and World Health Organization. Joint FAO/WHO working group report on drafting guidelines for the evaluation of probiotics in food. 2002. http://www.un.org/youthenvoy/2013/09/fao-food-and-agriculture-organization-of-the-united-nations/
8. Hill C, Guarner F, Reid G et al. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11 (8): 506–14.
9. GOST R 52349-2005 «Produkty pishchevye. Produkty pishchevye funktsional'nye. Terminy i opredeleniia». M.: Standartinform, 2015. [in Russian]
10. Sanders ME, Guarner F, Guerrant R et al. An update on the use and investigation of probiotics in health and disease. Gut 2013; 62: 787–96.
11. Davenport ER, Sanders JG, Song SJ et al. The human microbiome in evolution. BMC Biol 2017; 15: 127.
12. Van Baarlen P, Wells JM, Kleerebezem M. Regulation of intestinal homeostasis and immunity with probiotic lactobacilli. Trends Immunol 2013; 34: 208–15.
13. Bian G, Gloor GB, Gong A et al. The Gut Microbiota of Healthy Aged Chinese Is Similar to That of the Healthy Young. mSphere 2017; 2 (5): e00327-17.
14. Odamaki T, Kato K, Sugahara H et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol 2016; 16: 90.
15. Jones RJ, Hussein HM, Zagorec M et al. Isolation of lactic acid bacteria with inhibitory activity against pathogens and spoilage organisms associated with fresh meat. Food Microbiol 2008; 25 (2): 228–34.
16. Paredes-Paredes M, Flores-Figueroa J, Dupont HL. Advances in the treatment of travelers' diarrhea. Curr Gastroenterol Rep 2011; 13 (5): 402–7.
17. Wullt M, Johansson Hagslätt ML, Odenholt I, Berggren A. Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent Clostridium difficile–associated diarrhea. Dig Dis Sci 2007; 52 (9): 2082–6.
18. Dickinson B, Surawicz CM. Infectious diarrhea: an overview. Curr Gastroenterol Rep 2014; 16 (8): 399.
19. Gedek BR. Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 1999; 42 (4): 261–4.
20. Shornikova AV, Casas IA, Mykkänen N et al. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis 1997; 16: 1103–7.
21. Gionchetti P, Rizzello F, Morselli C et al. High-dose probiotics for the treatment of active pouchitis. Dis Colon Rectum 2007; 50: 2075–82.
22. Saxelin, M. Colonization of the human gastrointestinal tract by probiotic bacteria (Lactobacillus GG). Nutrition Today 1996; 31: 5S–9S.
23. Goldenberg JZ, Lytvyn L, Steurich J et al. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2015; 12: CD004827.
24. Labdoor. Probiotics rankings. 2016. https://labdoor.com/rankings/probiotics
25. Thomas LV, Suzuki K, Zhao J. Probiotics: a proactive approach to health. A symposium report. Br J Nutr 2015; 114 (1): S1–S15.
26. Gosudarstvennyi reestr lekarstvennykh sredstv Rossiiskoi Federatsii. http:// grls.rosminzdrav.ru/ [in Russian]
27. Osipova I.G., Evlashkina V.F., Davydov D.S., Sakanian E.I. Obshchie farmakopeinye stat'i na preparaty probiotiki dlia gosudarstvennoi Farmakopei RF XIII izdaniia – pervyi opyt v mirovoi farmakopeinoi praktike. Mezhdunar. zhurn. prikladnykh i fundamental'nykh issledovanii. 2016; 6 (2): 272–6. [in Russian]
28. OFS.1.7.1.0008.15 Probiotiki. http://pharmacopoeia.ru/ofs-1-7-1-0008-15-probiotiki/ [in Russian]
29. Mazankova L.N., Lykova E.A. Probiotiki: kharakteristika preparatov i vybor v pediatricheskoi praktike. Detskie infektsii. 2004; 1: 18–23. [in Russian]
30. Guarner F, Khan AG, Garisch J et al. Всемирная гастроэнтерологическая организация. Практические рекомендации. Пробиотики и пребиотики. http://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probioti... / Guarner F, Khan AG, Garisch J et al. Vsemirnaia gastroenterologicheskaia organizatsiia. Prakticheskie rekomendatsii. Probiotiki i prebiotiki. http://www.worldgastroenterology.org/guidelines/global-guidelines/probiotics-and-prebiotics/probioti... [in Russian]
31. 2011 Levels of Evidence. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/index.aspx?o=5653
32. Lau CS, Chamberlain RS. Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Int J Gen Med 2016; 9: 27–37.
33. Hamad A, Fragkos KC, Forbes A. A systematic review and meta-analysis of probiotics for the management of radiation induced bowel disease. Clin Nutr Edinb Scotl 2013; 32 (3): 353–60.
34. Dang Y, Reinhardt JD, Zhou X, Zhang G. The effect of probiotics supplementation on Helicobacter pylori eradication rates and side effects during eradication therapy: a meta-analysis. PloS One 2014; 9 (11): e111030.
Авторы
Е.Ю.Плотникова*, Ю.В.Захарова
ФГБОУ ВО «Кемеровский государственный медицинский университет» Минздрава России. 650056, Россия, Кемерово, ул. Ворошилова, д. 22а
*eka-pl@rambler.ru
Kemerovo State Medical University of the Ministry of Health of the Russian Federation. 650056, Russian Federation, Kemerovo, ul. Voroshilova, d. 22a
*eka-pl@rambler.ru
ФГБОУ ВО «Кемеровский государственный медицинский университет» Минздрава России. 650056, Россия, Кемерово, ул. Ворошилова, д. 22а
*eka-pl@rambler.ru
________________________________________________
Kemerovo State Medical University of the Ministry of Health of the Russian Federation. 650056, Russian Federation, Kemerovo, ul. Voroshilova, d. 22a
*eka-pl@rambler.ru
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.